Assessment of Visual Performance With Virtual Reality After Cataract Surgery

Sponsor
The University of Hong Kong (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06015334
Collaborator
Janssen, LP (Industry)
114
2
12

Study Details

Study Description

Brief Summary

The proposed randomized clinical trial aims to compare visual performance, measured using VR simulations, in cataract patients implanted either with bilateral trifocal IOL or bilateral monofocal IOL with monovision. The hypothesis is that patients implanted with trifocal IOL would exhibit superior visual performance, in both daytime and nighttime conditions, compared to those with a monofocal IOL with monovision.

Condition or Disease Intervention/Treatment Phase
  • Procedure: cataract surgery with implantation of intraocular lens
N/A

Detailed Description

Cataract surgery provides an opportunity to restore the quality of life by improving vision. While monofocal intraocular lenses (IOLs) implantation with monovision has been a common approach for cataract surgery, it may result in limited clarity at the intermediate distance and reduced depth perception. The advent of multifocal IOLs has expanded the possibilities, potentially offering increased visual performance in different ranges of vision. However, the benefits of multifocal IOLs in everyday activities are not fully understood due to the lack of task-based investigations.

To address this gap, a virtual reality-based approach is proposed to simulate daily activities and assess visual performance. This innovative method can provide insights into how multifocal IOLs enhance activities requiring good binocular vision at varying distances, a capability monofocal IOLs may lack. A randomized clinical trial is suggested to compare the TECNIS Synergy multi-focal IOL with the TECNIS monofocal IOL in monovision. Unlike its bifocal predecessors, the TECNIS Synergy IOL is trifocal, providing clear vision at near, intermediate, and far distances. The hypothesis is that patients implanted with the TECNIS Synergy IOL will demonstrate superior visual performance in simulated day and night conditions compared to those implanted with monofocal IOLs and monovision.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
114 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Patients with cataract will receive implantation of bilateral trifocal IOL (TECNIS Synergy) implantation or bilateral monofocal IOL (Tecnis monofocal) with monovision.Patients with cataract will receive implantation of bilateral trifocal IOL (TECNIS Synergy) implantation or bilateral monofocal IOL (Tecnis monofocal) with monovision.
Masking:
Single (Participant)
Masking Description:
Patients will remain unaware of their specific study arm assignments until the completion of the study.
Primary Purpose:
Treatment
Official Title:
Applying Virtual Reality to Compare Visual Performance Following Bilateral Implantation of TECNIS Synergy vs TECNIS Monofocal Intraocular Lens With Monovision in Patients With Cataract: A Randomized Controlled Trial.
Anticipated Study Start Date :
Oct 1, 2023
Anticipated Primary Completion Date :
Sep 30, 2024
Anticipated Study Completion Date :
Sep 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Bilateral implantation of trifocal intraocular lens

Patients will receive bilateral implantation of TECNIS Synergy intraocular lens

Procedure: cataract surgery with implantation of intraocular lens
Cataract surgery with implantation of bilateral trifocal IOL (TECNIS Synergy) implantation or bilateral monofocal IOL (Tecnis monofocal) with monovision.

Active Comparator: Bilateral monofocal intraocular lens implantation with monovision

Patients will receive bilateral implantation of TECNIS monofocal intraocular lens

Procedure: cataract surgery with implantation of intraocular lens
Cataract surgery with implantation of bilateral trifocal IOL (TECNIS Synergy) implantation or bilateral monofocal IOL (Tecnis monofocal) with monovision.

Outcome Measures

Primary Outcome Measures

  1. Overall Virtual reality (VR) performance score [Pre-operation, Month3]

    VR performance score measured from all VR simulations

Secondary Outcome Measures

  1. Task-specific VR performance score [Pre-operation, Month3]

    VR performance score measured from an individual VR simulation

  2. Binocular reading speed assessment [Pre-operation, Month3]

    Reading speed assessed by the MNRead acuity chart

  3. Binocular contrast sensitivity [Pre-operation, Month3]

    Contrast sensitivity assessed by Pelli-Robson contrast sensitivity chart

  4. Distance visual acuity [Pre-operation, Day1, Week1, Month1, Month3]

    Monocular and binocular uncorrected and corrected distance visual acuity

  5. Intermediate (66 cm) visual acuity [Month3]

    Monocular and binocular uncorrected and distance-corrected intermediate (66 cm) visual acuity

  6. Near (40 cm) visual acuity [Month3]

    Monocular and binocular uncorrected and distance-corrected near (40 cm) visual acuity

  7. Binocular defocus curve [Month3]

    Binocular defocus curve (from +1.0D to -4.0D) under photopic conditions (85 candela [cd]/m2)

  8. Photic phenomena [Pre-operation, Month3]

    Evaluation of photic phenomena by the 30-item quality of vision questionnaire

  9. Quality of life assessment [Pre-operation, Month3]

    National Eye Institute 25-item Visual Function Questionnaire Rasch score

Eligibility Criteria

Criteria

Ages Eligible for Study:
35 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Bilateral cataract

  • Regular corneal astigmatism

  • Corneal endothelium cell count >2000 cells/mm2

  • Clear intraocular media other than cataract

Exclusion Criteria:
  • Concomitant ocular diseases

  • Irregular corneal aberration

  • Capsular instability

  • Systemic disease that may affect vision

  • History of other intraocular surgery

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • The University of Hong Kong
  • Janssen, LP

Investigators

  • Principal Investigator: Christopher Leung, MD, MB ChB, The University of Hong Kong

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Professor Christopher K.S. Leung, Clinical Professor, The University of Hong Kong
ClinicalTrials.gov Identifier:
NCT06015334
Other Study ID Numbers:
  • H022_Protocol_VR Cataract
First Posted:
Aug 29, 2023
Last Update Posted:
Aug 29, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
Yes
Keywords provided by Professor Christopher K.S. Leung, Clinical Professor, The University of Hong Kong
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 29, 2023